Bookmark

Add to MyYahoo RSS

BioMarin Pharmaceutical News

News on BioMarin Pharmaceutical (Ticker: BMRN) continually updated from thousands of sources around the net.

Tuesday | BioSpace

BioMarin Pharmaceutical Inc. To Present At Upcoming Investor Conferences

BioMarin Pharmaceutical Inc. , today announced that management will participate in three upcoming investor conferences.

Comment?

Related Topix: Startups, New York, Investment Banking, Morgan Stanley European Fund, Financial Services, Morgan Stanley

Tuesday | AmericanBankingNews.com

BioMarin Pharmaceutical Given Average Recommendation of "Buy" by Brokerages

Shares of BioMarin Pharmaceutical have earned a consensus rating of "Buy" from the seventeen brokerages that are covering the stock, ARN reports .

Comment?

Related Topix: Startups

Fri Aug 15, 2014

AmericanBankingNews.com

BioMarin Pharmaceutical Given Average Rating of "Buy" by Brokerages

BioMarin Pharmaceutical has been given a consensus recommendation of "Buy" by the seventeen analysts that are covering the stock, AmericanBankingNews.com reports .

Comment?

Related Topix: Startups

Thu Aug 07, 2014

Sys-Con Media

Biotech Equities Technical Analysis -- BioMarin Pharma, Merrimack...

However the gains were not broad based as six out of ten sectors ended the session in negative.

Comment?

Related Topix: Startups, Sangamo Biosciences, Biotech, Medicine, Dyax, Healthcare Industry, Bind Biosciences, ZIOPHARM Oncology, Zio

Mon Aug 04, 2014

AmericanBankingNews.com

Insider Selling: Daniel K. Spiegelman Sells 2,229 Shares of BioMarin Pharmaceutical Stock

BioMarin Pharmaceutical CFO Daniel K. Spiegelman sold 2,229 shares of the company's stock in a transaction that occurred on Friday, August 1st.

Comment?

Related Topix: Startups

Sat Aug 02, 2014

AmericanBankingNews.com

BioMarin Pharmaceutical PT Raised to $82.00 at Nomura

The firm currently has a "neutral" rating on the stock. Nomura's price objective would suggest a potential upside of 32.36% from the company's current price.

Comment?

Related Topix: Startups

Fri Aug 01, 2014

The Business Journal

BioMarin starts new San Rafael buildings

BioMarin Pharmaceutical, Inc. , is breaking ground on a three-story building at its headquarters campus that will become key to the fast-growing company's pipeline of treatments for rare diseases and disorders.

Comment?

Related Topix: Startups, San Rafael, CA, Marin County, CA, Novato, CA

Wed Jul 30, 2014

Freshnews

Regeneron and Sanofi Announce Plan to Use Priority Review Voucher For Alirocumab U.S. FDA Submission

Regeneron Pharmaceuticals, Inc. and Sanofi today announced that the Companies intend to use a U.S. Food and Drug Administration rare pediatric disease priority review voucher in connection with the Biologics License Application submission for alirocumab.

Comment?

Related Topix: Biotech, Medicine, Regeneron Pharmaceuticals, Healthcare Industry, Food and Drug Administration, Startups, Genzyme General

AmericanBankingNews.com

BioMarin Pharmaceutical (BMRN) Posts Quarterly Earnings, Beats Estimates By $0.18 EPS

BioMarin Pharmaceutical released its earnings data on Wednesday. The company reported EPS for the quarter, beating the Thomson Reuters consensus estimate of by $0.18, AR Network reports.

Comment?

Related Topix: Startups

BioSpace

BioMarin Pharmaceutical Inc. Announces Second Quarter 2014 Financial Results

BioMarin Pharmaceutical Inc. today announced financial results for the second quarter ended June 30, 2014.

Comment?

Related Topix: Startups

•••
•••
•••
•••
•••

Ashburn Jobs

•••
•••
•••
•••